Michael Howell of CrossBorder Capital highlights Bitcoin as the most liquidity-sensitive asset globally, linking its behavior closely to monetary inflation alongside gold. He suggests a portfolio combining Bitcoin and gold, potentially shifting towards more Bitcoin as institutional interest grows, with an equal split as a future possibility. Howell also discusses broader economic factors like rising bond yields, the U.S. debt situation, and liquidity cycles, noting $70,000 as a critical support level for Bitcoin's price. These insights underscore Bitcoin's evolving role in financial markets amid changing liquidity and inflation dynamics.
Bitcoin liquidity outlook provides context for cryptocurrency trends on Pluang. For readers following crypto markets, here is Pluang's snapshot as of Oct 21, 2026 02:31 WIB: 44 of 50 major cryptocurrencies rose today. Notable movers include XNO at Rp6.161 with a 4.11% increase and 100% buy order activity, XTZ at Rp5.591 up 3.71% with 67% sell orders, and CAKE at Rp40.064 rising 3.50% with 82% buy orders.
Moody's is expected to report Q3 2026 earnings of around $4.25 per share on revenue near $2.08 billion, driven by steady demand for credit ratings and growth in Moody's Analytics, especially from recurring subscriptions and AI tools. While Moody's In...
Raymond James increased its price target for Rapport Therapeutics to $86 following positive Phase 2 trial results of RAP-219, a drug treating acute bipolar mania. The trial showed statistically significant improvement in patients and a favorable safe...
Heartland Express reported a third-quarter 2026 revenue decline of 8.7% to $179.5 million, missing analyst estimates. Despite lower revenue, the company returned to profitability with a net income of $1.0 million, compared to a loss last year. The op...
Catholic Medical Mission Board (CMMB) held a ribbon-cutting ceremony for its new Distribution Center at the Brethren Service Center in New Windsor, Maryland. This move enhances CMMB's Access to Medicines Program by expanding operational capacity and ...
Piper Sandler upgraded Myriad Genetics from Underweight to Neutral and set a $5.00 price target after the company agreed to sell its prenatal health testing business to Labcorp for $210 million in cash. This sale includes several prenatal tests and i...
